Movatterモバイル変換


[0]ホーム

URL:


CA2268719C - Blood collection tube assembly - Google Patents

Blood collection tube assembly
Download PDF

Info

Publication number
CA2268719C
CA2268719CCA002268719ACA2268719ACA2268719CCA 2268719 CCA2268719 CCA 2268719CCA 002268719 ACA002268719 ACA 002268719ACA 2268719 ACA2268719 ACA 2268719ACA 2268719 CCA2268719 CCA 2268719C
Authority
CA
Canada
Prior art keywords
plasma
chamber
tube
magnetic
plastic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002268719A
Other languages
French (fr)
Other versions
CA2268719A1 (en
Inventor
Joel L. Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson and CofiledCriticalBecton Dickinson and Co
Priority claimed from CA 2077981external-prioritypatent/CA2077981C/en
Publication of CA2268719A1publicationCriticalpatent/CA2268719A1/en
Application grantedgrantedCritical
Publication of CA2268719CpublicationCriticalpatent/CA2268719C/en
Anticipated expirationlegal-statusCritical
Expired - Lifetimelegal-statusCriticalCurrent

Links

Landscapes

Abstract

The present invention includes a plastic container deposited with a silicon oxide based film and a method for depositing a silicon oxide based film as a barrier.
The film is useful for providing an effective barrier against gas permeability in containers and for extending shelf-life of containers, especially plastic evacuated blood collection devices.

Description

BLOOD COLLECTION TUBE ASSEMBLY
This is a division of Canadian Patent Application Serial No. 2,077,981 filed September 10, 1992.
BACKGROUND OF THE INVENTION
1. Field of the Invention This invention relates to barrier coatings for providing an effective barrier against gas and water permeability for containers, especially plastic evacuated blood collection tubes.
2. Description of the Related Art Containers made of polymers have found an ever increasing use as replacements for glass and metal containers. In particular, polyethylene terephthalate (PET) has been used in the fabrication of bottles.
20. Bottles manufactured with PET exhibit excellent mechanical properties. However, such bottles are deficient when used for storing and transporting oxygen sensitive liquids. It has been found that containers made with PET are not sufficiently gas impervious and therefore do not maintain a desirable shelf-life. See, for example, U.S. Patent No. 3,733,309.
These deficiencies have restricted the use of polymers in containers, despite the advantages of polymers. 'These advantages include mechanical, thermal and optical properties and the adaptability of fabrication techniques for polymers, allowing the containers to be homogeneous, laminated and or coated.
A further advantage of containers made from polymers is that they are generally light weight, less breakable and inexpensive to manufacture. Injection molding and extrusion, both possible methods for making articles from plastic, are inexpensive. With injection molding, large cavitation and decreased production times can increase production volume. Additionally, the injection molding process is not labor intensive and can be easily automated.
It is also known in the art that polymers such as PET can be laminated to an ethylene/vinyl alcohol copolymer (EVOH) to improve the gas barrier permeable properties of the polymer. Blends of PET and EVOH have been found to be useful in making containers having improved barriers to gas permeability. See, for example, U.S. Patent Nos. 3,595,740.

However, each of these materials has drawbacks.
Ethylene-vinyl alcohol-based polymers lose barrier properties upon exposure to water and packages of this material cannot generally undergo retort, i.e., heating under pressurized steam for pasteurization. Vinylidene chloride-based polymers have been recognized as having excellent gas-barrier properties, but preparation of such vinylidene chloride-based polymers must generally be done under high pressure. Further, since vinylidene chloride-based barrier materials include halogen atoms, the disposal of such materials via incineration poses - environmental problems. In addition, both vinylidene chloride-based polymers and ethylene-vinyl alcohol based polymers exhibit loss of adhesion after undergoing retort.
It is also known in the art that a silicon oxide based film could provide an effective barrier to oxygen permeability for two dimensional substrates as disclosed in European Patent Application, Publication Number 0 299 754. However, such films have not been used on three.
dimensional substrates such as plastic blood collection tubes.
With the increased emphasis on the use of plastic medical products, a special need exists for improving the barrier properties of articles made of polymers.
Such medical products that would derive a considerable benefit from improving their barrier properties include, but are not limited to, collection tubes and particularly those used for blood collection.
Blood collection tubes require certain performance standards to be acceptable for use in medical applications. Such performance standards include the ability to maintain greater than about 90% original draw volume over a one year period, to be radiation sterilizable and to be noninterfering in tests and analysis.
A critical performance standard of the blood collection tube is the draw volume retention. Draw volume retention depends on the existence of a partial vacuum, or reduced pressure, inside the tube. The draw _- volume changes in direct proportion to the change in vacuum (reduced pressure). Therefore, draw volume retention is dependent on good vacuum retention.

For example, it is important to maintain the vacuum over a period of time in order to provide appropriate storage life for those tubes prior to their
-3-being used. That is, it is important for the vacuum level to be maintained for a period of time prior to the time when a technician or a nurse uses the tube for collecting a blood sample.
Radiation sterilizable means that after the tube is exposed to certain levels of radiation in the sterilization process, there is substantially no change in optical or mechanical and functional properties.
Noninterference in performance of a tube's specifications means that the materials of the tube, such as glass or plastic materials do not interfere with testing and analysis that 'is typically performed on blood in the tube. Such tests include but are not limited to hematology, blood chemistry, blood typing, toxicology analysis and therapeutic drug monitoring.
Furthermore, the tube'must be capable of being subjected to automated machinery such as centrifuges.
Typically, plastic evacuated blood collection tubes have paper or foil labels applied over the outer surface. However, paper labels do not improve the barrier properties of the plastic tube and foil such as ZS a metallic foil, is not transparent.
- Therefore, it is desirable to be able to coat a plastic evacuated blood collection tube with a suitable.
barrier composition or blend thereof which can ~be convenient~.y applied to a plastic tube while not obscuring its contents, that would be able to meet certain performance standards and be effective and usable in medical applications.
-4-SUMMARY OF THE INVENTION
In accordance with the invention in one aspect there is provided a method of depositing a thin silicon oxide based film on a plastic blood collection tube by a plasma process within a previously evacuated chamber, comprising the steps of: (a) providing said chamber with a gas stream that includes an oxygen component, an inert gas component and volatized organosilicon material desired to be deposited on said plastic collection tube; (b) esta-blishing within said chamber a glow discharge plasma derived from the gas of said stream, said chamber having therein a combination of magnetic and electric fields whereby to establish said plasma from one or more of the components of the gas stream; (c) flowing said gas stream into the plasma while confining at least a portion o:f the plasma therein; (d) removably positioning the plastic tube adjacent to the confined plasma without any electrical connection therewith such that said thin film may be deposited thereon; (e) said magnetic field being generated such that it provides a substantial magnetic flux directed against said plastic tube to enhance the formation of the thin film thereon; and (f) effecting movement of said plastic tube adjacent to the confined plasma to apply a uniform film thereon.
In one embodiment of the invention the step of generating a magnetic field includes positioning wit)zin said chamber a first magnetic pole oriented to face said plasma and a second magnetic pole oriented to face away from said plasma.
In another embodiment of the invention the step of generating a magnetic field includes positioning within said chamber a magnetic structure having a surface adjacent said plasma that is characterized by a magnetic flux distribution function in substantially any direction thereacross which varies from one magnetic strength of
-5-one polarity separated by a lesser magnetic strength of another polarity.
Preferably, the plasma is confined by means of unbalanced magnetron.
Preferably, the vacuum pump is in fluid communication with the chamber.
DESCRIPTION OF THE DRAWINGS
FIG. 1 is a perspective view of a typical blood collection tube with a stopper.
FIG. 2 is a longitudinal sectional view of the tube of FIG 1 taken along line 2-2.
FIG. 3 is a longitudinal sectional view of a tube-shaped container similar to the tube of FIG. 1 without a stopper.
FIG. 4 is a longitudinal sectional view of a tube-shaped container similar to the tube of FIG. 1 with a stopper.
FIG. 5 is a schematic diagram illustrating a plasma system.
FIG. 6 is a schematic diagram illustrating a side sectional view of the plasma deposition chamber and :its associated equipment as related to FIG. 5.
-6-DETAILED DESCRIPTION
The present invention may be embodied in other specific forms and is not limited to any specific embodiment described in detail which is merely exemplary. Various other modifications will be apparent to and readily made by those skilled in the art without departing from the scope and spirit of the invention.
The scope of the invention will be measured by the l0 aPPended claims and their equivalents.
Referring to the drawings in which like reference characters refer to like parts throughout the several views thereof, FIGS. 1 and 2 show a typical blood collection tube l0, having an open end 16, a closed end 18 and stopper 14 which includes a lower annular portion or skirt 15 which extends into and presses against the inside walls 12 of the tube for maintaining stopper 14 in place. FIG. 2 schematically illustrates that there are three mechanisms for a change in vacuum in a blood collection tube: (A) gas permeation through the stopper material; (B) gas permeation through the tube material and (C) leak at the closure-tube interface. Therefore, when there is substantially no gas permeation and no leak, there is good vacuum retention and good draw volume retention.
FIG. 3 shows the preferred embodiment of the invention, a plastic .tube coated with a silicon oxide based film. The preferred embodiment includes many components which are substantially identical to the components of FIGS. 1 and 2. Accordingly, similar components performing similar functions will be numbered identically to those components of FIGS. 1 and 2, except that a suffix "a" will be used to identify those components in FIG. 3.
Referring now to FIG. 3, the preferred embodiment of the invention, collection tube assembly 20 comprises a plastic tube 10a, having an open end 16a and a closed end 18a. A silicon oxide based film 25 extends over a substantial portion of the length of the tube which is upon the entire outer surface of the tube. As shown in FIG. 3, film label 25 covers all of the tube with the exception of open end 16a thereof.
FIG. 4 illustrates an alternate embodiment of the invention, wherein collection tube assembly 40 comprises stopper 48 in place for closing open end 41 of tube 42. As can be seen, stopper 48 includes an annular upper portion 50 which extends over the top edge of tube 42 as well as the top edge of film 45. Stopper 48 includes a lower annular portion or skirt 49 which extends into and presses against the inside walls of tube 42 for maintaining stopper 48 in place. Also, the annular lower skirt 49 of stopper 48 defines a well 52 which, in turn, defines a septum portion 53 of stopper 48 for receiving a cannula therethrough. Thus, the user, once receiving a container such as that shown in FIG. 4 with a sample contained therein, may insert a cannula through septum 53 for receiving part or all of the contents in tube 42 to perform various tests on a sample.
Covering a substantial portion of the length of the tube is film 45. Film 45 covers substantially most of the tube with the exception of open end 41 thereof.
_g_ FIG. 4 differs from the embodiment in FIG. 3 in that the tube is first evacuated with the simultaneous placement of stopper 48 therein followed by the application of film 45 thereover the tube.
An alternate embodiment of the invention also includes a film incorporating both the upper portion of the stopper, as well as the entire container tube. Such an embodiment may be utilized, for example,_for sealing the container with the stopper in place r Once a sample has been placed in the tube, the sample cannot be tampered with by removal of the stopper. Additionally, serrations could be included at the tube, stopper interface. The serrations may be registered so that it can be determined if the sealed container has been tampered with.
It will be understood by practitioners-in-the-art, such tubes may contain reagents in the form of additives or coatings on the inner wall of the tube.
The silicon oxide based film forms a clear or translucent barrier on the outer surface of the plastic tube. The film is preferably translucent so that the contents of the plastic tube are visable to the observer at the same time identifying information may be displayed over the film after it is applied ~to the plastic tube.
The method for depositing a hard silicon oxide based film on an article is preferably conducted in a previously evacuated chamber of glow discharge from a gas stream. The gas stream preferably comprises at _g_ least three components: a volatilized organosilicon component, an oxygen component and an inert gas component.
Suitable organosilicon compounds for the gas stream are liquid at about ambient temperature and when volatilized have a boiling point above about ambient temperature and include methylsilane, dimethysilane, trimethylsilane, diethylsilane, propylsilane, phenylsil-ane, hexamethyldisilane, 1,1,2,2-tetramethyl disilane, bis(trimethylsilane) methane, bis(dimethylsilyl) methane, hexamethyldisiloxane, vinyl trimethoxy silane, vinyl triethyoxy silane, ethylmethoxy silane, ethyltri methoxy silane, divinyltetramethyldisiloxane, divinyl-hexamethyltrisiloxane, and trivinylpentamethyltrisilox-ane.
Among the preferred organosilicons are 1,1,3,3-tetramethyldisiloxane, hexamethyldisiloxane, vinyltrimethylsilane, methyltrimethoxysilane, vinyltri-methoxysilane and hexmethyldisilane.
The inert gas of the gas stream preferably is helium or argon. Most preferably the inert gas is helium.
- The volatilized organosilicon component is preferably admixed with the oxygen component and the inert gas component before being flowed into the chamber. The quantities of these gases being so admixed are controlled by flow controllers so as to adjustably control the flow rate ratio of the gas stream components.

The organosilicon compound and oxygen of the gas stream during the deporting are preferably in a flow rate ratio between about 1.2:1 to about 1:1.8. When the inert gas is helium or argon, then the preferred flow rate ratio of organosilicon compound, oxygen and inert gas is about 1 to 1.8:1.5 to 1.8 to 2.3.
In addition to the necessary organosilicon, oxygen and inert gas in the gas stream, minor amounts (not greater than about 1:1 with respect to the organosilicon, more preferably about 0.4 to 1.1:1 with respect to the organosilicon) of one or more additional compounds in gaseous form may be included for particular desired properties. These additional compounds include, but are not limited to a lower hydrocarbon such as propylene, methane or acetylene, or nitrogen. In particular, nitrogen increases the deposition rate, improves the transmission and reflection optical properties on glass, and varies the index of refraction in response to varied amounts of N2. The addition of nitrous oxide to the gas stream increases the deposition rate and improves the optical properties, but tends to decrease the film hardness.
A particularly preferred gas stream composition has 20 to 40 SCCM organosilicon, 20 to 40 SCCM 02, 40 to 60 SCCM He, 1 to 10 SCCM propylene and 5 to ~20 SCCM
N2.
A flow discharge plasma is established in the previously evacuated chamber which is derived from one or more of the gas stream components, and preferably is derived from the gas stream itself. The article is positioned in the plasma, preferably adjacent the confined plasma, and the gas stream is controllably flowed into the plasma. The article is preferably conveyed into and out of the plasma adjacent the confined plasma for a sufficient number of passes to obtain the desired film and thickness.
Referring to FIG. 5, the system for depositing a silicon oxide based film is schematically illustrated.
IO The system comprises an enclosed reaction chamber 70 in which a plasma is formed and in which a collection tube 72, is placed for depositing a thin film of material on it. The collection tube can be any vacuum compatible material, such as plastic. One or more gases I5 are supplied to the reaction chamber by a gas supply system 73. An electric field is created by a power supply 74, and a low pressure is maintained by a pressure control system 76. An optical emission spectrometer 77 is connected through an optical fiber 20 light transmission medium 78 to the reaction chamber in some appropriate manner to couple the visible and near visible (especially the ultraviolet range) emission of the plasma to the spectrometer. A quartz window 80 in a side wall of the reaction chamber can be used to 25 optically couple the optical emission spectrometer with the chamber. A general control system 83, including a computer control portion, is connected to each of the other components of the system in a manner to receive status information from and send controlling commands to 30 them.
The reaction chamber can be of an appropriate type to perform any of the plasma-enhanced chemical vapor deposition (PECVD) or plasma polymerization process.

FIG. 6 shows a detailed side sectional schematic of the system of FIG. S, for a PECVD or plasma polymerization process. In particular, reaction chamber 70 is divided into a load lock compartment 84 and a process compartment 86 by an isolation gate valve 87. The pressure control system 76 includes a mechanical pump 88 connected to the load lock compartment 84 by a valve 90. The pressure control system also includes diffusion pumps 92 and 93, and an associated mechanical pump 94. The diffusion pump 92 is connected to the load lock compartment 84 through an isolation gate valve 96 and an adjustable baffle 97. Similarly, the diffusion pump 93 is connected to the process compartment 86 through an isolation gate valve 98 and an adjustable baffle 100. Baffle 100 is controlled by the system control 83, while a coating process is being carried out, in order to maintain the internal pressure at a desired value.
The collection tube to be coated is first loaded into the load lock compartment 84 with the valve 87 closed. The mechanical pump 88 then reduces the pressure most of the way to the high vacuum region. The diffusion pump 92 is then operated to reduce the pressure further, to about 5 x 10 6 Torr. The operating pressure is about 46 microns for a PECVD or plasma polymerization process and is achieved by flowing the process gases into the reaction chamber and throttling diffusion pump 93 using baffle 100.
During loading and unloading operations, diffusion pump 93 maintains the process compartment 86 at the operating pressure. Once the load lock compartment 84 is reduced to base pressure, the valve 87 is opened and tube 72 moved into process compartment 86.

A typical deposition process involves passing tube 72 back and forth through a plasma region 104, a number of times in order that the thin film deposited on the outer surface of the tube has a desired uniform thickness.
A magnetron is positioned within process compartment 86, formed of a magnetic structure 106 and a cathode 107. Power supply 74 has its output IO co~ected between cathode 107 and a metallic body of the process compartment. The magnetron creates an appropriate combination of magnetic and electrical fields in plasma region 104 in order to create a plasma there when the proper gases are introduced into 15 the process compartment. The tube is maintained electrically isolated and is passed directly through the plasma region. This is accomplished by a plurality of rollers 102. -20 The gaseous components necessary for the plasma to form in plasma region 104 are introduced into process compartment 86 by a conduit 108. Gas flows within process compartment 86 from diffusion pump 93. A
pair of baffles 11o and 112 on either side of the 25 magnetron help to conf ine the gas f low to plasma region 104.
A plastic blood collection tube coated with the silicon oxide based film or blends thereof may 30 effectively be used in such applications as routine chemical analysis, biological inertness, hematology, blood chemistry, blood typing, toxicology analysis or therapeutic drug monitoring and other clinical tests involving body fluids.

It will be understood that it makes no difference whether the plastic composite container is evacuated or not evacuated in accordance with this invention. The presence of barrier composition on the outer surface of the container has the effect of maintaining the general integrity of the container holding a sample so that it may be properly disposed of without any contamination to the user. In addition, the barrier composition makes the container stronger overall because of the cushioning characteristics of the barrier composition.
The silicon oxide based film or blends thereof used in accordance with this disclosure, may contain conventional additives and ingredients which do not I5 adversely affect the properties of articles made therefrom.
A further aspect of the invention is a method for forming plastic containers with a polymer blend composition. and then coating the container with a silicon oxide based film.
Various other modifications will be apparent to and may be readily made by those skilled in the art without departing from the scope and spirit of the invention.
The following examples are not limited to any specific embodiment of the invention, but are only exemplary.

c~vrunr r i METHOD FOR COATING A
PLASTIC BLOOD COLLECTION TUBE
WITH A SILICON OXIDE BASED FILM
An enclosed reaction chamber is evacuated to a base pressure of not greater than about 3 x IO 6 Torr. The load lock is vented to atmosphere while the IO chamber is maintained under high vacuum. Then the load lock is evacuated with the plastic tube loaded therein.
The chamber pressure is adjusted to a desired value by adjusting the baffle over the diffusion pump. The Ioad lock diffusion pump is closed and the valve isolating I5 the load lock and the chamber is opened. After the pressure in the chamber is stabilized, the power supply is turned on and adjusted to the desired value and a glow discharge plasma is established in the chamber. An emission spectrum from the control program is used to 20 find the appropriate oxygen to inert gas ratio. The organosilicon flow into the chamber is then adjusted until the desired oxygen to inert gas ratio is obtained. The plastic tube is then conveyed back and forth through the plasma region until the desired 25 coating thickness is achieved while continuing to monitor the process conditions. Once the desired film thickness is obtained, the system is shut down and the coated tube is removed.

PLASTIC TUBE COATED WITH A SILICOL~I OXIDE BASED FILM
AS COMPARED TO PLASTIC TUBE WITHOUT
A BARB I ER COMPOS I T I OL~1 Saturated plastic tubes, 13x75mm, made of polypropylene, with and without a silicon oxide based film, were placed in a controlled environment at 40°C
and 4 ATM. The 40°C and 4 ATM provide conditions for accelerated ambient aging.
The silicon oxide based film was applied to tubes in category B. Tubes in category A, the control group, did not have a barrier coating.
Each tube was tested for oxygen transmission rates using the OxTran'~1000 instrument by Mocon, Inc.
02 Transmission Rate Tube (cc per tube per day) A 0.09066 B 0.0011 The results show that a lower 02 transmission rate was achieved with a silicon oxide based film on a plastic container as compared to a plastic tube with no barrier coating.
35 * Trade-mark L'STT MDT ~' COMPARISON OF PLASTIC TUBES COATED AND FLAT SUBSTRATES
COATED WITH A SILICON OXIDE BASED FILM
Flat substrates made of polyethyleneterephthalate (PET), 1 mil in thickness,. and saturated plastic tubes, 13x75mm, made of PET were coated with a silicon oxide based film. The oxygen permeabilities of the substrates were measured at 25°C and the oxygen transmission rate of the plastic tubes were predicted based on the permeability data results of the substrates.
The results of the oxygen transmission rates are given below:
Oxygen Oxygen Transmission Rate Permeability SAMPLE (CC/Tube/Day) (cc/M /atm/Day) PET Tube 0.0023 ---PET/Si02 Tube O.Q001 ---PET 1 mil substrate --- 80 PET/Si02 substrate --- 1.06 The results show that a lower transmission rate will be achieved with the silicon oxide based film on a plastic tube as compared to a plastic tube with no silicon oxide based film.

Claims (5)

Claims:
1. A method of depositing a thin silicon oxide based film on a plastic blood collection tube by a plasma process within a previously evacuated chamber, comprising the steps of:
(a) providing said chamber with a gas stream that includes an oxygen component, an inert gas component and volatized organosilicon material desired to be deposited on said plastic collection tube;
(b) establishing within said chamber a glow discharge plasma derived from the gas of said stream, said chamber having therein a combination of magnetic and electric fields whereby to establish said plasma from one or more of the components of the gas stream;
(c) flowing said gas stream into the plasma while confining at least a portion of the plasma therein;
(d) removably positioning the plastic tube adjacent to the confined plasma without any electrical connection therewith such that said thin film may be deposited thereon;
(e) said magnetic field being generated such that it provides a substantial magnetic flux directed against said plastic tube to enhance the formation of the thin film thereon; and (f) effecting movement of said plastic tube adjacent to the confined plasma to apply a uniform film thereon.
2. The method according to claim 1, wherein the step of generating a magnetic field includes positioning within said chamber a first magnetic pole oriented to face said plasma and a second magnetic pole oriented to face away from said plasma.
3. The method according to claim 1, wherein the step of generating a magnetic field includes positioning within said chamber a magnetic structure having a surface adjacent to said plasma that is characterized by a magnetic flux distribution function in substantially any direction thereacross which varies from one magnetic strength of one polarity separated by a lesser magnetic strength of another polarity.
4. The method according to claim 1, wherein the plasma is confined by means of an unbalanced magnetron which creates said combined electric and magnetic fields.
5. The method according to claim 1, wherein a vacuum pump is in fluid communication with the chamber.
CA002268719A1991-10-031992-09-10Blood collection tube assemblyExpired - LifetimeCA2268719C (en)

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
US77127591A1991-10-031991-10-03
US771,2751991-10-03
CA 2077981CA2077981C (en)1991-10-031992-09-10Blood collection tube assembly

Related Parent Applications (1)

Application NumberTitlePriority DateFiling Date
CA 2077981DivisionCA2077981C (en)1991-10-031992-09-10Blood collection tube assembly

Publications (2)

Publication NumberPublication Date
CA2268719A1 CA2268719A1 (en)1993-04-04
CA2268719Ctrue CA2268719C (en)2001-08-28

Family

ID=25675512

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CA002268719AExpired - LifetimeCA2268719C (en)1991-10-031992-09-10Blood collection tube assembly

Country Status (1)

CountryLink
CA (1)CA2268719C (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO2014085348A3 (en)*2012-11-302015-01-08Sio2 Medical Products, Inc.Controlling the uniformity of pecvd deposition on medical syringes, cartridges, and the like
US9272095B2 (en)2011-04-012016-03-01Sio2 Medical Products, Inc.Vessels, contact surfaces, and coating and inspection apparatus and methods
US9458536B2 (en)2009-07-022016-10-04Sio2 Medical Products, Inc.PECVD coating methods for capped syringes, cartridges and other articles
US9545360B2 (en)2009-05-132017-01-17Sio2 Medical Products, Inc.Saccharide protective coating for pharmaceutical package
US9554968B2 (en)2013-03-112017-01-31Sio2 Medical Products, Inc.Trilayer coated pharmaceutical packaging
US9572526B2 (en)2009-05-132017-02-21Sio2 Medical Products, Inc.Apparatus and method for transporting a vessel to and from a PECVD processing station
US9664626B2 (en)2012-11-012017-05-30Sio2 Medical Products, Inc.Coating inspection method
US9662450B2 (en)2013-03-012017-05-30Sio2 Medical Products, Inc.Plasma or CVD pre-treatment for lubricated pharmaceutical package, coating process and apparatus
US9764093B2 (en)2012-11-302017-09-19Sio2 Medical Products, Inc.Controlling the uniformity of PECVD deposition
US9863042B2 (en)2013-03-152018-01-09Sio2 Medical Products, Inc.PECVD lubricity vessel coating, coating process and apparatus providing different power levels in two phases
US9878101B2 (en)2010-11-122018-01-30Sio2 Medical Products, Inc.Cyclic olefin polymer vessels and vessel coating methods
US9903782B2 (en)2012-11-162018-02-27Sio2 Medical Products, Inc.Method and apparatus for detecting rapid barrier coating integrity characteristics
US9937099B2 (en)2013-03-112018-04-10Sio2 Medical Products, Inc.Trilayer coated pharmaceutical packaging with low oxygen transmission rate
US10189603B2 (en)2011-11-112019-01-29Sio2 Medical Products, Inc.Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus
US11066745B2 (en)2014-03-282021-07-20Sio2 Medical Products, Inc.Antistatic coatings for plastic vessels
US11077233B2 (en)2015-08-182021-08-03Sio2 Medical Products, Inc.Pharmaceutical and other packaging with low oxygen transmission rate
US11116695B2 (en)2011-11-112021-09-14Sio2 Medical Products, Inc.Blood sample collection tube
US11624115B2 (en)2010-05-122023-04-11Sio2 Medical Products, Inc.Syringe with PECVD lubrication
US12257371B2 (en)2012-07-032025-03-25Sio2 Medical Products, LlcSiOx barrier for pharmaceutical package and coating process

Cited By (41)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US9572526B2 (en)2009-05-132017-02-21Sio2 Medical Products, Inc.Apparatus and method for transporting a vessel to and from a PECVD processing station
US10390744B2 (en)2009-05-132019-08-27Sio2 Medical Products, Inc.Syringe with PECVD lubricity layer, apparatus and method for transporting a vessel to and from a PECVD processing station, and double wall plastic vessel
US10537273B2 (en)2009-05-132020-01-21Sio2 Medical Products, Inc.Syringe with PECVD lubricity layer
US9545360B2 (en)2009-05-132017-01-17Sio2 Medical Products, Inc.Saccharide protective coating for pharmaceutical package
US9458536B2 (en)2009-07-022016-10-04Sio2 Medical Products, Inc.PECVD coating methods for capped syringes, cartridges and other articles
US11624115B2 (en)2010-05-122023-04-11Sio2 Medical Products, Inc.Syringe with PECVD lubrication
US9878101B2 (en)2010-11-122018-01-30Sio2 Medical Products, Inc.Cyclic olefin polymer vessels and vessel coating methods
US11123491B2 (en)2010-11-122021-09-21Sio2 Medical Products, Inc.Cyclic olefin polymer vessels and vessel coating methods
US9272095B2 (en)2011-04-012016-03-01Sio2 Medical Products, Inc.Vessels, contact surfaces, and coating and inspection apparatus and methods
US11724860B2 (en)2011-11-112023-08-15Sio2 Medical Products, Inc.Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus
US11884446B2 (en)2011-11-112024-01-30Sio2 Medical Products, Inc.Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus
US11148856B2 (en)2011-11-112021-10-19Sio2 Medical Products, Inc.Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus
US10189603B2 (en)2011-11-112019-01-29Sio2 Medical Products, Inc.Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus
US11116695B2 (en)2011-11-112021-09-14Sio2 Medical Products, Inc.Blood sample collection tube
US10577154B2 (en)2011-11-112020-03-03Sio2 Medical Products, Inc.Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus
US12257371B2 (en)2012-07-032025-03-25Sio2 Medical Products, LlcSiOx barrier for pharmaceutical package and coating process
US9664626B2 (en)2012-11-012017-05-30Sio2 Medical Products, Inc.Coating inspection method
US9903782B2 (en)2012-11-162018-02-27Sio2 Medical Products, Inc.Method and apparatus for detecting rapid barrier coating integrity characteristics
US9764093B2 (en)2012-11-302017-09-19Sio2 Medical Products, Inc.Controlling the uniformity of PECVD deposition
WO2014085348A3 (en)*2012-11-302015-01-08Sio2 Medical Products, Inc.Controlling the uniformity of pecvd deposition on medical syringes, cartridges, and the like
US10363370B2 (en)2012-11-302019-07-30Sio2 Medical Products, Inc.Controlling the uniformity of PECVD deposition
AU2013352436B2 (en)*2012-11-302018-10-25Sio2 Medical Products, Inc.Controlling the uniformity of PECVD deposition on medical syringes, cartridges, and the like
CN105705676B (en)*2012-11-302018-09-07Sio2医药产品公司Control the uniformity of the PECVD depositions on injector for medical purpose, cylindrantherae etc.
KR20150091374A (en)*2012-11-302015-08-10에스아이오2 메디컬 프로덕츠, 인크.Controlling the uniformity of pecvd deposition on medical syringes, cartridges, and the like
US10201660B2 (en)2012-11-302019-02-12Sio2 Medical Products, Inc.Controlling the uniformity of PECVD deposition on medical syringes, cartridges, and the like
KR102211950B1 (en)2012-11-302021-02-04에스아이오2 메디컬 프로덕츠, 인크.Controlling the uniformity of pecvd deposition on medical syringes, cartridges, and the like
CN105705676A (en)*2012-11-302016-06-22Sio2医药产品公司Controlling the uniformity of PECVD deposition on medical syringes, cartridges, and the like
US11406765B2 (en)2012-11-302022-08-09Sio2 Medical Products, Inc.Controlling the uniformity of PECVD deposition
US9662450B2 (en)2013-03-012017-05-30Sio2 Medical Products, Inc.Plasma or CVD pre-treatment for lubricated pharmaceutical package, coating process and apparatus
US10016338B2 (en)2013-03-112018-07-10Sio2 Medical Products, Inc.Trilayer coated pharmaceutical packaging
US9937099B2 (en)2013-03-112018-04-10Sio2 Medical Products, Inc.Trilayer coated pharmaceutical packaging with low oxygen transmission rate
US11298293B2 (en)2013-03-112022-04-12Sio2 Medical Products, Inc.PECVD coated pharmaceutical packaging
US11344473B2 (en)2013-03-112022-05-31SiO2Medical Products, Inc.Coated packaging
US11684546B2 (en)2013-03-112023-06-27Sio2 Medical Products, Inc.PECVD coated pharmaceutical packaging
US9554968B2 (en)2013-03-112017-01-31Sio2 Medical Products, Inc.Trilayer coated pharmaceutical packaging
US10912714B2 (en)2013-03-112021-02-09Sio2 Medical Products, Inc.PECVD coated pharmaceutical packaging
US12239606B2 (en)2013-03-112025-03-04Sio2 Medical Products, LlcPECVD coated pharmaceutical packaging
US10537494B2 (en)2013-03-112020-01-21Sio2 Medical Products, Inc.Trilayer coated blood collection tube with low oxygen transmission rate
US9863042B2 (en)2013-03-152018-01-09Sio2 Medical Products, Inc.PECVD lubricity vessel coating, coating process and apparatus providing different power levels in two phases
US11066745B2 (en)2014-03-282021-07-20Sio2 Medical Products, Inc.Antistatic coatings for plastic vessels
US11077233B2 (en)2015-08-182021-08-03Sio2 Medical Products, Inc.Pharmaceutical and other packaging with low oxygen transmission rate

Also Published As

Publication numberPublication date
CA2268719A1 (en)1993-04-04

Similar Documents

PublicationPublication DateTitle
EP0535810B1 (en)Blood collection tube assembly
CA2268719C (en)Blood collection tube assembly
US5686157A (en)Blood collection tube assembly
CA2195048C (en)Blood collection tube assembly
KR100186808B1 (en) Blood collection tube assembly
KR100188289B1 (en)Blood collection tube assembly
KR100188291B1 (en) Blood collection tube assembly
US5683771A (en)Blood collection tube assembly
US6054188A (en)Non-ideal barrier coating architecture and process for applying the same to plastic substrates
US5545375A (en)Blood collection tube assembly
JP7371163B2 (en) Pharmaceutical packaging and other packaging with low oxygen transmission rates
US5654054A (en)Barrier coating
AU694530B2 (en)Plastic articles of reduced gas transmission and method therefor
EP0787824B1 (en)Container with a non-ideal barrier coating sequence composition
JPH08175528A (en)Method for forming silicon oxide film of uniform film thickness on three-dimensional container made of plastic material
WO2019191269A1 (en)Vessels, containers, and surfaces coated with water barrier coatings
CA2277679C (en)Blood collection tube assembly
EP1074588A2 (en)Barrier coating and process for applying the same to plastic substrates
AU709857B2 (en)Blood collection tube assembly
CA2271504A1 (en)Blood collection tube assembly
MXPA97000637A (en)Pipe assembly for san collection

Legal Events

DateCodeTitleDescription
EEERExamination request
MKEXExpiry

[8]ページ先頭

©2009-2025 Movatter.jp